Topics
- A consideration of the new law on various agreements with healthcare professionals: collaboration agreement, research agreements, consultancy agreements, clinical trial agreements, pharmacoviligance arrangements, PMCFU agreement, educational grants, speaker agreements and sponsorships
- The new law and its impact on crucial areas of practice in the life sciences sector
- A practical guide to structuring and implementing a compliance regime considering the requirements in Germany, the UK and the Netherlands
- How to handle Bribery Act considerations in commercial agreements with non-HCPs and M&A transactions
- Some practical "war stories" and scenarios
Who should Attend
Directors, Vice Presidents, Heads, Partners, Associates and Managers involved in Mergers and Acquisition, Clinical Development and Liaison, Business Development, Alliances, Compliance, Venture Capital, General Counsel, Finance, Contract Administration and Corporate Counsel.
